Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
116.60
+3.29 (2.90%)
Oct 27, 2026, 4:00 PM EDT - Market closed
Incyte Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, Incyte stock has a consensus rating of "Buy" and an average price target of $129.54. The average 1-year stock price forecast is 11.10% higher than the current stock price, while the lowest is $86 (-26.24%) and the highest is $157 (+34.65%).
Price Target: $129.54 (+11.10%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Incyte stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 10 | 10 | 10 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 15 | 14 | 15 | 15 | 15 | 15 |
| Sell | 1 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Total | 28 | 26 | 27 | 28 | 28 | 28 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Hold Maintains $115 | Hold | Maintains | $115 | -1.37% | Oct 27, 2026 |
| BMO Capital | BMO Capital | Hold Maintains $130 | Hold | Maintains | $130 | +11.49% | Oct 27, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $150 | Buy | Maintains | $150 | +28.64% | Oct 27, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $152 | Buy | Reiterates | $152 | +30.36% | Oct 27, 2026 |
Chris Yu Morgan Stanley No rating | Morgan Stanley | Hold Maintains $119 | Hold | Maintains | $119 | +2.06% | Oct 27, 2026 |
Financial Forecast
Revenue This Year
5.93B
from 5.14B
Increased by 15.38%
Revenue Next Year
6.24B
from 5.93B
Increased by 5.15%
EPS This Year
3.10
from 6.80
Decreased by -54.39%
EPS Next Year
8.65
from 3.10
Increased by 179.02%
EPS and Forward PE are based on non-GAAP adjusted numbers.